LeMaitre Vascular - LMAT Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" LMAT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LMAT, but not buy additional shares or sell existing shares.
View LMAT analyst ratings or view top-rated stocks.

1 brokers have issued 12 month price targets for LeMaitre Vascular's stock. Their LMAT share price forecasts range from $50.00 to $50.00. On average, they predict the company's stock price to reach $50.00 in the next year. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for LMAT or view top-rated stocks among Wall Street analysts.

LeMaitre Vascular's stock was trading at $50.23 on January 1st, 2022. Since then, LMAT stock has decreased by 7.6% and is now trading at $46.42.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our LMAT earnings forecast.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted its earnings results on Thursday, October, 27th. The medical instruments supplier reported $0.25 EPS for the quarter, missing the consensus estimate of $0.28 by $0.03. The medical instruments supplier had revenue of $39.03 million for the quarter, compared to the consensus estimate of $40.13 million. LeMaitre Vascular had a net margin of 13.22% and a trailing twelve-month return on equity of 9.33%.

LeMaitre Vascular declared a quarterly dividend on Thursday, October 27th. Investors of record on Thursday, November 17th will be given a dividend of $0.125 per share on Thursday, December 1st. This represents a $0.50 annualized dividend and a dividend yield of 1.08%. The ex-dividend date is Wednesday, November 16th.
Read our dividend analysis for LMAT.

LeMaitre Vascular (NASDAQ:LMAT) pays an annual dividend of $0.50 per share and currently has a dividend yield of 1.08%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 52.08%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, LMAT will have a dividend payout ratio of 42.37% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for LMAT.

LeMaitre Vascular issued an update on its fourth quarter 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share (EPS) guidance of $0.24-$0.29 for the period, compared to the consensus earnings per share estimate of $0.32. The company issued revenue guidance of $39.80 million-$42.20 million, compared to the consensus revenue estimate of $41.87 million.

13 employees have rated LeMaitre Vascular Chief Executive Officer George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among the company's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), Boeing (BA) and Salesforce (CRM).

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

LeMaitre Vascular's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.85%), Conestoga Capital Advisors LLC (8.41%), Vanguard Group Inc. (6.57%), Copeland Capital Management LLC (5.57%), Geneva Capital Management LLC (4.06%) and State Street Corp (3.23%). Insiders that own company stock include David B Roberts, George W Lemaitre, George W Lemaitre, John A Roush, Joseph P Pellegrino Jr, Lawrence J Jasinski and Trent G Kamke.
View institutional ownership trends.

Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LMAT stock can currently be purchased for approximately $46.42.

LeMaitre Vascular (NASDAQ:LMAT) has a market capitalization of $1.02 billion and generates $154.42 million in revenue each year. The medical instruments supplier earns $26.91 million in net income (profit) each year or $0.96 on an earnings per share basis.

The company employs 450 workers across the globe.

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The official website for the company is www.lemaitre.com. The medical instruments supplier can be reached via phone at (781) 221-2266 or via fax at 781-425-5049.